Clinical development plan: 2-difluoromethylornithine (DFMO)

J Cell Biochem Suppl. 1994:20:147-65.

Authors

G J Kelloff¹, J A Crowell, C W Boone, V E Steele, R A Lubet, P Greenwald, D S Alberts, J M Covey, L A Doody, G G Knapp, et al.

Affiliation

¹ Chemoprevention Branch, National Cancer Institute (NCI), Bethesda, MD 20892, USA.

PMID: 7616740

No abstract available

MeSH terms

Animals
Clinical Trials as Topic / methods*
Clinical Trials as Topic / standards
Dogs
Drug Approval*
Eflornithine / pharmacology*
Eflornithine / therapeutic use*
Humans
Mice
Neoplasms / prevention & control
Rats

Substances

Eflornithine